Idiopathic Thrombocytopenia Purpura Clinical Trials

• AMG 531 Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00415532 - Active, not recruiting
  Idiopathic Thrombocytopenic Purpura; Thrombocytopenia; Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP); Thrombocytopenic Purpura
  
• Retrospective & Prospective Observational Study of Subjects With ITP
  ClinicalTrials.gov Identifier: NCT00454857 - Active, not recruiting
  Idiopathic Thrombocytopenic Purpura; Thrombocytopenia; Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP); Thrombocytopenic Purpura
  
• Safety and Efficacy Study of AMG 531 to Treat ITP in Pediatric Subjects
  ClinicalTrials.gov Identifier: NCT00515203 - Recruiting
  Idiopathic Thrombocytopenic Purpura; Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP); Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
  
• An Open Label Study of AMG 531 for Subjects With ITP
  ClinicalTrials.gov Identifier: NCT00508820 - Recruiting
  Idiopathic Thrombocytopenic Purpura; Thrombocytopenia; Thrombocytopenic Purpura
  
• AMG 531 Treatment of Thrombocytopenic Subjects with Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to Splenectomy
  ClinicalTrials.gov Identifier: NCT00102336 - Active, not recruiting
  Thrombocytopenia
  
• AMG 531 Treatment of Thrombocytopenic Subjects with Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy
  ClinicalTrials.gov Identifier: NCT00102323 - Active, not recruiting
  Thrombocytopenia
  
• Open Label Extension Study of AMG 531 in Thrombocytopenic Subjects with Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
  ClinicalTrials.gov Identifier: NCT00116688 - Recruiting
  Thrombocytopenia
  
• SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo in Adults with Refractory Immune Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00102739 - Active, not recruiting
  Purpura, Thrombocytopenic, Idiopathic
  
• Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag
  ClinicalTrials.gov Identifier: NCT00370331 - Active, not recruiting
  Idiopathic Thrombocytopenic Purpura
  
• Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT)
  ClinicalTrials.gov Identifier: NCT00424177 - Active, not recruiting
  Chronic Idiopathic Thrombocytopenic Purpura
  
• Clinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura in Adults
  ClinicalTrials.gov Identifier: NCT00426270 - Recruiting
  Idiopathic Thrombocytopenic Purpura
  
• Pharmacokinetics and Pharmacodynamic Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00244257 - Recruiting
  Idiopathic Thrombocytopenic Purpura
  
• Open Label Extension Study of AMG 531 in Japanese Subjects With ITP
  ClinicalTrials.gov Identifier: NCT00440037 - Recruiting
  Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
  
• A Study of MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura.
  ClinicalTrials.gov Identifier: NCT00475423 - Recruiting
  Idiopathic Thrombocytopenic Purpura
  
• A Study to Find How Safe and Effective GAMMAPLEX® is in Subjects With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
  ClinicalTrials.gov Identifier: NCT00504075 - Recruiting
  Chronic Idiopathic Thrombocytopenic Purpura
  
• Treatment of ITP with Subcutaneously Administered Anti-D
  ClinicalTrials.gov Identifier: NCT00128882 - Recruiting
  Idiopathic Thrombocytopenic Purpura
  
• A Trial to Treat Patients with ITP Who Do Not Achieve a Durable Response to Rituxan Alone
  ClinicalTrials.gov Identifier: NCT00161564 - Recruiting
  Idiopathic Thrombocytopenic Purpura (ITP)
  
• Phase II Study of Rituximab in Patients With Immune Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00005652 - Active, not recruiting
  Purpura, Thrombocytopenic, Idiopathic
  
• Study of Veltuzumab (hA20) at Different Doses in Patients With ITP
  ClinicalTrials.gov Identifier: NCT00547066 - Active, not recruiting
  Purpura, Thrombocytopenic, Idiopathic; Autoimmune Thrombocytopenic Purpura; Purpura, Thrombocytopenic, Autoimmune
  
• Cohort of Children With Acute Immune or Idiopathic Thrombocytopenic Purpura (ITP) : a Prospective Study in Pays De La Loire
  ClinicalTrials.gov Identifier: NCT00331357 - Not yet recruiting
  Acute Idiopathic Thrombocytopenic Purpura
  
• An Epidemiological Study of Subjects with Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers
  ClinicalTrials.gov Identifier: NCT00005570 - Completed
  Purpura, Thrombocytopenic, Idiopathic; immune thrombocytopenic purpura
  
• Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP)
  ClinicalTrials.gov Identifier: NCT00540423 - Not yet recruiting
  Chronic Idiopathic Thrombocytopenic Purpura
  
• A Phase 1, Open-Label, Multiple-Dose, Dose Escalation Study of the Safety and Tolerability of Staphylococcal Protein A in Adult Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
  ClinicalTrials.gov Identifier: NCT00571467 - Not yet recruiting
  Idiopathic Thrombocytopenic Purpura (ITP)
  
• Pilot Study of Rituximab for the Treatment of Acute Immune Thrombocytopenic Purpura (ITP)
  ClinicalTrials.gov Identifier: NCT00372892 - Recruiting
  Purpura, Thrombocytopenic, Idiopathic
  
• Study of Doxil in the Treatment of Patients with Refractory Idiopathic Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00107913 - Recruiting
  Autoimmune Thrombocytopenic Purpura
  
• Evaluating the Safety and Efficacy of AMG 531 in Thrombocytopenic Subjects with Immune Thrombocytopenic Purpura (ITP)
  ClinicalTrials.gov Identifier: NCT00111475 - Completed
  Idiopathic Thrombocytopenic Purpura
  
• Safety Study of AMG 531 in Japanese Subjects With ITP
  ClinicalTrials.gov Identifier: NCT00305435 - Completed
  Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
  
• Efficacy and Safety of IVIG-L in ITP Patients
  ClinicalTrials.gov Identifier: NCT00151840 - Completed
  Purpura, Thrombocytopenic, Idiopathic
  
• Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects with Chronic Idiopathic Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00162006 - Completed
  Idiopathic Thrombocytopenic Purpura
  
• Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00467571 - Recruiting
  Chronic Idiopathic Thrombocytopenic Purpura; Helicobacter Pylori Infection
  
• Rituximab as Second Line Treatment for ITP
  ClinicalTrials.gov Identifier: NCT00344149 - Recruiting
  Idiopathic Thrombocytopenic Purpura
  
• (Eltrombopag Extended Dosing Study)in Adults
  ClinicalTrials.gov Identifier: NCT00351468 - Recruiting
  Idiopathic Thrombocytopenic Purpura
  
• SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C
  ClinicalTrials.gov Identifier: NCT00110799 - Active, not recruiting
  Hepatitis C; Thrombocytopenia
  
• Ig NextGen 10% in ITP Patients
  ClinicalTrials.gov Identifier: NCT00362349 - Recruiting
  Idiopathic Thrombocytopenic Purpura (ITP)
  
• High Dose Dexamethasone Vs. Conventional Dose Prednisolone in Adult ITP
  ClinicalTrials.gov Identifier: NCT00451594 - Recruiting
  Idiopathic Thrombocytopenic Purpura
  
• IGIV Study for Chronic ITP Patients Ages 3-70
  ClinicalTrials.gov Identifier: NCT00511147 - Not yet recruiting
  Idiopathic Thrombocytopenic Purpura
  
• Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With ITP
  ClinicalTrials.gov Identifier: NCT00441090 - Recruiting
  Chronic Idiopathic Thrombocytopenic Purpura (ITP)
  
• A Trial of Antenatal Treatment of Alloimmune Thrombocytopenia
  ClinicalTrials.gov Identifier: NCT00194987 - Recruiting
  Alloimmune Thrombocytopenia; Fetal Alloimmune Thrombocytopenia
  
• Mechanism of Thrombocytopenia in Infants
  ClinicalTrials.gov Identifier: NCT00333333 - Recruiting
  Thrombocytopenia; Small for Gestational Age (SGA); Preeclampsia
  
• A Multi-Center, Observational Safety Registry of Subjects with Idiopathic Parkinson''s Disease Previously Treated with Intraputaminal Infusion of Liatermin
  ClinicalTrials.gov Identifier: NCT00148369 - Active, not recruiting
  Idiopathic Parkinson''s Disease
  
• A Study on the Prevalence of Heparin-Induced Thrombocytopenia in Cardiovascular Patients
  ClinicalTrials.gov Identifier: NCT00198575 - Active, not recruiting
  Heparin-Induced Thrombocytopenia
  
• Treatment of Autoimmune Thrombocytopenia (AITP)
  ClinicalTrials.gov Identifier: NCT00001630 - Recruiting
  Autoimmune Disease; Autoimmune Hemolytic Anemia; Thrombocytopenia
  
• Use of Rituximab Treatment in Addition to Standard Care for Newly Presenting Thrombotic Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00251277 - Recruiting
  Thrombotic Thombocytopenic Purpura; TTP; Hematology
  
• Long-Term Open-Label Trial in Idiopathic RLS Subjects
  ClinicalTrials.gov Identifier: NCT00498186 - Active, not recruiting
  Idiopathic Restless Legs Syndrome
  
• Efficacy of Steroid Versus Steroid Plus Cyclophosphamide for Severe Henoch-Schoenlein Purpura
  ClinicalTrials.gov Identifier: NCT00190229 - Active, not recruiting
  Henoch-Schoenlein Purpura
  
• Heparin Induced Thrombocytopenia: Pharmacoeconomics
  ClinicalTrials.gov Identifier: NCT00456001 - Active, not recruiting
  Heparin Induced Thrombocytopenia (HIT)
  
• Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection
  ClinicalTrials.gov Identifier: NCT00239733 - Recruiting
  Thrombocytopenia; Hepatitis C; HIV Infections
  
• Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002665 - Active, not recruiting
  Thrombocytopenia; Leukemia, Lymphocytic; Neutropenia
  
• Efficacy and Safety Study of Argatroban to Treat Heparin-Induced Thrombocytopenia
  ClinicalTrials.gov Identifier: NCT00198588 - Recruiting
  Heparin-Induced Thrombocytopenia
  
• Trial of Prognostic Factors and Surgical Methods for the Treatment of Idiopathic Macular Holes
  ClinicalTrials.gov Identifier: NCT00302328 - Active, not recruiting
  Idiopathic Macular Hole Stage 2 and 3
  
• Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00031980 - Active, not recruiting
  Anemia; Chronic Lymphocytic Leukemia; Neutropenia; Thrombocytopenia
  
• Long-Term Treatment Study of MRA for Polyarticular Juvenile Idiopathic Arthritis(pJIA)
  ClinicalTrials.gov Identifier: NCT00144625 - Active, not recruiting
  polyarticular juvenile idiopathic arthritis
  
• Long-Term Treatment Study of MRA for Systemic Juvenile Idiopathic Arthritis(sJIA)
  ClinicalTrials.gov Identifier: NCT00144612 - Active, not recruiting
  systemic juvenile idiopathic arthritis
  
• Efficacy and Safety of Oral Bosentan in Patients with Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00071461 - Active, not recruiting
  Idiopathic Pulmonary Fibrosis
  
• Safety and Efficacy Study To Compare Uniplas With Cryosupernatant Plasma In Thrombotic Thrombocytopenic Purpura (TTP)
  ClinicalTrials.gov Identifier: NCT00411801 - Recruiting
  Thrombotic Thrombocytopenic Purpura (TTP)
  
• Double-Blind, Multicenter, Sham Surgery Controlled Study of CERE-120 For Efficacy and Safety in Subjects With Idiopathic Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00400634 - Active, not recruiting
  Idiopathic Parkinson's Disease
  
• Transfusion Medicine/Hemostasis Clinical Research Network
  ClinicalTrials.gov Identifier: NCT00081718 - Recruiting
  Purpura, Thrombocytopenic; Blood Disease
  
• Patient Plasma Response and Outcome in Septic Shock with Thrombocytopenia Associated Multiple Organ Failure in Children
  ClinicalTrials.gov Identifier: NCT00118664 - Recruiting
  Septic Shock; Thrombocytopenia; Multiple Organ Failure
  
• Daclizumab to Treat Chronic Immune Thrombocytopenia
  ClinicalTrials.gov Identifier: NCT00049725 - Completed
  Thrombocytopenia
  
• Minocycline Therapy for Lung Scarring in Patients With Idiopathic Pulmonary Fibrosis - a Pilot Study
  ClinicalTrials.gov Identifier: NCT00203697 - Active, not recruiting
  Idiopathic Pulmonary Fibrosis
  
• The Significance of Glucose Intolerance in the Pathogenesis of Idiopathic Axonal Polyneuropathy
  ClinicalTrials.gov Identifier: NCT00228345 - Active, not recruiting
  Idiopathic Axonal Polyneuropathy; Abnormal OGTT
  
• Three-Arm Study of the Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00287716 - Active, not recruiting
  Idiopathic Pulmonary Fibrosis
  
• A Double-Blind, Randomized Control Trial Comparing Botulinum Toxin Type A (Botox) and Placebo in the Treatment of Idiopathic Clubfoot
  ClinicalTrials.gov Identifier: NCT00152347 - Recruiting
  Idiopathic clubfoot (talipes equinovarus)
  
• A Dose and Schedule Finding Trial of AMG 531 for Treatment of Chemotherapy Induced Thrombocytopenia (CIT) in Subjects With Lymphoma
  ClinicalTrials.gov Identifier: NCT00283439 - Recruiting
  Chemotherapy-Induced Thrombocytopenia; Hodgkin's Lymphoma; Non-Hodgkin's Lymphoma
  
• Angiomax in Patients with HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE)
  ClinicalTrials.gov Identifier: NCT00073580 - Active, not recruiting
  Thrombocytopenia; Thrombosis; Cardiac Disease; Coronary Artery Bypass Surgery
  
• Pirfenidone for the Treatment of Patients with Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis (PF/IPF)
  ClinicalTrials.gov Identifier: NCT00080223 - Active, not recruiting
  Idiopathic Pulmonary Fibrosis; Pulmonary Fibrosis
  
• Aspirin in Patients With Myocardial Infarction and Thrombocytopenia
  ClinicalTrials.gov Identifier: NCT00501345 - Recruiting
  Thrombocytopenia; Myocardial Infarction
  
• Stalevo in Early Wearing-Off Patients
  ClinicalTrials.gov Identifier: NCT00125567 - Active, not recruiting
  Idiopathic Parkinson''s Disease
  
• Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00287729 - Active, not recruiting
  Idiopathic Pulmonary Fibrosis
  
• Efficacy of Botox in Patients with Idiopathic Clubfoot
  ClinicalTrials.gov Identifier: NCT00152334 - Active, not recruiting
  Idiopathic clubfoot (talipes equinovarus)
  
• Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases
  ClinicalTrials.gov Identifier: NCT00006055 - Active, not recruiting
  Purpura, Schoenlein-Henoch; Graft Versus Host Disease; Anemia, Hemolytic, Autoimmune; Rheumatoid Arthritis; Churg-Strauss Syndrome; ...
  
• Study to Evaluate Efficacy of Shunt Operation for Idiopathic Normal Pressure Hydrocephalus
  ClinicalTrials.gov Identifier: NCT00221091 - Active, not recruiting
  Idiopathic Normal Pressure Hydrocephalus
  
• DAPHNE (Duodopa in Advanced Parkinson''s: Health Outcomes & Net Economic Impact).
  ClinicalTrials.gov Identifier: NCT00141518 - Active, not recruiting
  advanced idiopathic Parkinson''s disease
  
• Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease
  ClinicalTrials.gov Identifier: NCT00010387 - Active, not recruiting
  Anemia, Hemolytic, Autoimmune; Felty Syndrome; Purpura, Thrombocytopenic; Autoimmune Diseases
  
• Interleukin-1 Receptor Antagonist (IL-1RA) (ANAKINRA) IN SEVERE SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS
  ClinicalTrials.gov Identifier: NCT00339157 - Active, not recruiting
  Systemic-Onset Juvenile Idiopathic Arthritis
  
• Screening for Hematology Branch Protocols
  ClinicalTrials.gov Identifier: NCT00001620 - Recruiting
  Anemia; Hematologic Neoplasm; Neutropenia; Pancytopenia; Thrombocytopenia
  
• The HIT-TRAP Trial
  ClinicalTrials.gov Identifier: NCT00196417 - Active, not recruiting
  Heparin-Induced Thrombocytopenia
  
• Effectiveness of Early Aggressive Drug Therapy in Poly-Juvenile Idiopathic Arthritis
  ClinicalTrials.gov Identifier: NCT00443430 - Recruiting
  Poly-Juvenile Idiopathic Arthritis; Juvenile Idiopathic Arthritis; Juvenile Rheumatoid Arthritis
  
• ADAMTS13 in Thrombotic Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00426686 - Recruiting
  Thrombotic Thrombocytopenic Purpura
  
• Zileuton for the Treatment of Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00262405 - Active, not recruiting
  Idiopathic Pulmonary Fibrosis
  
• Endothelial Progenitor Cells and Pulmonary Idiopathic Arterial Hypertension
  ClinicalTrials.gov Identifier: NCT00551408 - Active, not recruiting
  Pulmonary Idiopathic Arterial Hypertension
  
• Heparin-Induced Thrombocytopenia Score Card Study
  ClinicalTrials.gov Identifier: NCT00489437 - Not yet recruiting
  Heparin Induced Thrombocytopenia
  
• A Study to Determine If Levetiracetam Will Assist Those Suffering from Chronic Idiopathic Axonal Polyneuropathy.
  ClinicalTrials.gov Identifier: NCT00156689 - Recruiting
  Chronic Idiopathic Axonal Polyneuropathy
  
• Trial of a Botulinum A Toxin (Botox) Injection in the Gastrocnemius Muscle in Children With Idiopathic Toe Walking
  ClinicalTrials.gov Identifier: NCT00175669 - Recruiting
  Idiopathic Toe Walking
  
• Identification of Donors of CD36-Deficient Platelets Among Japanese Individuals on the NIH Campus
  ClinicalTrials.gov Identifier: NCT00015639 - Completed
  Thrombocytopenia
  
• HSP-Glomerulonephritis Trial: MP vs CyA
  ClinicalTrials.gov Identifier: NCT00425724 - Active, not recruiting
  Purpura, Schoenlein-Henoch
  
• EUROPAC-2 - Pain Treatment of Hereditary and Idiopathic Pancreatitis
  ClinicalTrials.gov Identifier: NCT00142233 - Recruiting
  Hereditary Pancreatitis and idiopathic chronic pancreatitis
  
• Biochemical Markers of Growth Response to GH Treatment in Children With Idiopathic Short Stature
  ClinicalTrials.gov Identifier: NCT00458263 - Recruiting
  Idiopathic Short Stature
  
• A Study to Determine whether Therapy with Daclizumab Will Benefit Patients with Bone Marrow Failure
  ClinicalTrials.gov Identifier: NCT00001962 - Recruiting
  Aplastic Anemia; Pure Red Cell Aplasia; Thrombocytopenic Purpura
  
• Phase I, Open-Label, Multi-Center, SIngle-Dose, Dose-Escalating, Safety, Tolerability and Pharmacokinetic Study of GC1008 in Patients with IPF
  ClinicalTrials.gov Identifier: NCT00125385 - Active, not recruiting
  Idiopathic Pulmonary Fibrosis; IPF
  
• Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
  ClinicalTrials.gov Identifier: NCT00396097 - Recruiting
  Idiopathic Short Stature
  
• Cancer in Inherited Bone Marrow Failure Syndromes
  ClinicalTrials.gov Identifier: NCT00027274 - Recruiting
  Fanconi's Anemia; Anemia, Diamond-Blackfan; Dyskeratosis Congenital; Thrombocytopenia; Neutropenia
  
• Safety and efficacy of an investigational drug in the prevention of thrombocytopenia in patients receiving myelosuppressive treatment regimens requiring platelet transfusion support.
  ClinicalTrials.gov Identifier: NCT00037791 - Completed
  Neoplasms; Thrombocytopenia; Multiple Myeloma; Lymphoma, Malignant
  
• Tipifarnib in Treating Patients With Myelofibrosis and Myeloid Metaplasia
  ClinicalTrials.gov Identifier: NCT00047190 - Active, not recruiting
  chronic idiopathic myelofibrosis; Polycythemia Vera; Essential Thrombocythemia
  
• Treatment of Idiopathic Pulmonary Fibrosis With Long Acting Octreotide
  ClinicalTrials.gov Identifier: NCT00463983 - Recruiting
  Idiopathic Pulmonary Fibrosis
  
• Clinical Study With QAX576 in Patients With Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00532233 - Recruiting
  Idiopathic Pulmonary Fibrosis
  
• Anticoagulant Therapy with Bivalirudin in the Performance of Percutaneous Coronary Intervention in patients with Heparin-Induced Thrombocytopenia (AT BAT, First Inning)
  ClinicalTrials.gov Identifier: NCT00043940 - Completed
  Heparin-Induced Thrombocytopenia; Thrombosis
  
• Somatropin + Leuprorelin vs Somatropin Alone vs Untreated Control in Pubertal Children With Idiopathic Short Stature
  ClinicalTrials.gov Identifier: NCT00355030 - Recruiting
  Idiopathic Short Stature (ISS)
  
• Safety and Efficacy Study of Transplantation of EPCs to Treat Idiopathic Pulmonary Arterial Hypertension
  ClinicalTrials.gov Identifier: NCT00372346 - Recruiting
  Idiopathic Pulmonary Arterial Hypertension
  
• The Efficacy and Safety of Desloratadine With Levocetirizine in Treatment of Chronic Idiopathic Urticaria
  ClinicalTrials.gov Identifier: NCT00346606 - Recruiting
  Chronic Idiopathic Urticaria; Urticaria